Background
Tuberculosis (TB) remains a global health threat and is one of the leading causes of death particularly human immunodeficiency virus (HIV) positive patients or among people living with acquired immunodeficiency syndrome [
1,
2]. In 2017, the World Health Organization (WHO) global estimates show that, approximately 10 million people became ill with TB and more than 1.5 million died from the disease [
1]. Over 94% of all TB deaths occurred in low- and middle-income countries (LMICs) including Ghana [
1]. Ghana is classified as one of the countries with the highest double burden of TB and HIV, with a combined TB/HIV mortality rate of 18 per 100,000 populations translating to about 10,440 deaths per annum [
3]. Early diagnosis and treatment of TB have been proven to be of greater benefits reducing morbidity and mortality as well as catastrophic cost related to TB treatment [
2,
4].
The Government of Ghana (GOG) in her quest to reduce the impact of TB on the population over the years have made efforts to expand TB diagnostic services in the country through procurement of GeneXpert MTB/RIF test for some rural health facilities and retooling of laboratories across the country’s hospitals. Despites the continuous effort been made by the GOG and international organization, in 2017, out of the 14,550 TB case notifications received in Ghana, 6% of the patients were tested with rapid diagnostics at the time of diagnosis [
5]. An average of 986 multi drug-resistant TB (MDR-TB) cases were reported in Ghana in the same period [
5]. It also estimated that just about a quarter of MDR-TB cases are been detected yearly in Ghana, of which just close to half get cured [
6,
7].
To reduce the burden of TB morbidity and mortality, more patients with TB need to be screened, diagnosed, and treated or prevented from developing TB illness in the first place [
2,
3]. Prevention of TB cases is particularly critical in rural and resource-limited settings, where access to point-of-care (POC) testing and diagnosis of patients with tuberculosis can be very much challenging. Most rural primary health care (PHC) facilities commonly lack laboratory infrastructure and the required human resource capacity to diagnose TB. One of the most effective ways to improve early diagnosis and treatment of patients with TB is to empower rural and resource-limited PHC clinics to be able to carry out POC testing for suspected TB patients. Our earlier survey of PHC clinics in the Upper East Region (UER), Ghana aimed at evaluating the accessibility of POC diagnostic services demonstrated poor availability of TB testing [
8]. In view of this, we aimed to assess the geographic accessibility to public health facilities providing TB testing services at POC in the UER, Ghana. To the best of our knowledge, no such study has been conducted before in the region and, we anticipate that the results will be useful for planning to reduce the catastrophic cost associated with TB diagnosis and treatment as well as towards achieving the End TB Strategy by 2035 [
9].
Discussion
Geographic access to care is difficult to measure hence the international community most often defined targets based on facility provision per capita [
14]. In this study, we assembled unique spatial data on health facilities providing TB testing services, population, and topographic landscape, as well as supporting survey to assess realistic levels of geographic accessibility to public health facilities providing TB testing services at POC in the UER. This study results show majority (62%) of the population travel beyond 10 km to access TB diagnostic testing in the region. It also revealed that TB diagnostic service was available in only ten health facilities in the UER which translates to approximately 125,000 people per facility considering the region’s current total population of 1,244,983. This study further revealed that four districts did not have any health facility providing TB diagnostic services. However, the spatial distribution of the public health facilities providing TB testing services were revealed to be dispersed in the region.
Although geographic accessibility is not the only determinant of access to health care, where service provision is sparse, and the population is predominantly rural, it plays a critical role for healthcare outcomes [
14]. Poor geographic accessibility to public health facilities providing TB testing services at POC revealed by this study implies patients in referred from PHC clinics in rural areas have to walk for hours or pay exorbitant transport fares to access TB diagnostic services [
15]. Patients often have the tendency to limit or utilize essential health care services closer to them [
16]. Majority of rural populations in low and middle income countries are farmers [
17]. Therefore, a clients may fail to go for a test or go back for test results when asked to come back the following day or week especially at certain times of the season [
18]. Dangisso et al. (2015) study in Ethiopia demonstrated TB case notification rates were higher in areas where people had good access to diagnostic and treatment facilities [
15]. Finnie et al. (2011) aimed to identify factors causing delayed diagnosis and treatment for tuberculosis in high TB/HIV burden African countries also demonstrated travel time associated with delays in patients returning for care [
19,
20]. Although the spatial distribution of the health facilities providing TB testing services were revealed to be dispersed in the UER, this is deemed desirable to maximize accessibility to TB testing services.
In this study we employed the geospatial methodology to assess the geographical distribution of health facilities providing TB testing services at POC and their proximity to the population. Spatial accessibility measures have been shown to be important policy tool for managing health care provision and reducing health disparities [
21,
22]. We used census data from the Ghana statistical service whiles also taking into consideration other geographic data and incorporated remote sensing of aerial data to accurately distribute population within all political boundaries. The application of remote sensing through satellite imagery afforded us the opportunity to observe locations that had settlements as well as enabled us to properly cite proposed health clinics without necessarily having to visit the region. Each population distribution data is unique because it takes into account, the prevailing conditions and spatial nature of each and every region [
23]. This study methodology enables us to identify poor geographic access to public health facilities for TB testing services in the UER. Health sector budgetary allocation of countries like Ghana is poor and most often supported by development partners, International organizations, and donors with many competing interests. Therefore, the spatial methodology adopted by this study has strength of informing policy makers to plan and implement TB diagnostic testing services in poor geographic access areas.
Despite the above-mentioned strengths of the study, the following limitations should be noted. Although, we assembled a comprehensive set of data describing the landscape, it is possible we may not have captured all local details such as the prevalence or incidence rate of TB in the UER. We therefore recommend future studies to focus on mapping and determining how many TB cases fall within ‘high’ versus ‘low’ accessible areas in the region. Also, using an assumed motorized tricycle speed of 20 km/hour to calibrate travel time may always not be applicable since other transportation options such as walking, use of a motorbike, bicycle or a car may be utilized by some patients to the health facilities. In addition, traveling time may be affected by seasonal changes, traffic, and other essential factors. Nonetheless, this study provided very useful information to help planning and improve geographical access to TB POC testing particularly for rural populations.
Efforts to reduce TB morbidity, mortality, and catastrophic cost associated with treatment by improving the quality and availability of diagnostic services and treatment in selected health facilities will have limited impact where long distances, poor infrastructure at the PHC level, lack of good roads and transport systems means patients referred from PHC clinics may be unable to access services timely. To improve TB care the WHO recommends TB testing alongside other POC test in resource-limited settings in its maiden list of essential diagnostics [
24]. Geographic accessibility is a key aspect of ensuring better health care and treatment for people and clearly, in the case of the UER as demonstrated by this study, a higher proportion of the populace are located at a significantly longer distance away from public health facilities providing TB testing services. Hence, this study proposed an improvement of at least 51 PHC clinics in the UER to enable them provide TB testing services. Improving road networks and making available faster and safer transport systems in rural areas in the region would also greatly improve travel time as well.
Conclusion
The study findings show poor geographic accessibility to public health facilities providing TB testing services at POC in UER, Ghana. The findings of this study have provided evidence-based information to help with planning and improving TB testing services targeting first rural PHC clinics located in poor geographic access areas in the region. Travelling long distances to access a health facility for TB testing outside one’s location can be a limiting factor for most suspected TB patients and hence, could affect the successes chalked so far toward the end TB strategy in the region. Long distances also may result in late diagnosis and treated as well as worsen the catastrophic cost currently associated with TB treatment in Ghana. To reduce the impact of TB infection, diagnosis, treatment, and related catastrophic cost related in Ghana and other LMICs, the measurement of geographical accessibility is very relevant to provide evidence-based strategies to improve TB care. We will like to recommend a replication of this study in high prevalence regions in Ghana and other TB high prevalence countries. We also recommend TB active case finding in low prevalence regions especially among high risk populations to facilitate achievement of the end TB strategy by 2035.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.